All Stories

  1. Algorithm-guided insulin therapy in hospitalized patients: current evidence, implementation challenges, and future perspectives
  2. Viral medicine: social media and new expectations of obesity treatment
  3. Entre el beneficio y el riesgo: el papel de los suplementos alimenticios en endocrinología
  4. Impacto de la semaglutida oral en la calidad de vida y parámetros metabólicos de los pacientes con diabetes mellitus tipo 2: un estudio observacional multicéntrico
  5. Segunda edición de las recomendaciones para «no hacer» de la Sociedad Española de Endocrinología y Nutrición (SEEN)
  6. Clinical Effectiveness of Oral Semaglutide in Women with Type 2 Diabetes: A Nationwide, Multicentre, Retrospective, Observational Study (Women_ENDO2S-RWD Substudy)
  7. Effects of oral semaglutide on kidney outcomes in people with type 2 diabetes: a nationwide, multicentre, retrospective, observational study (Renal_ENDO2S-RWD substudy)
  8. Comment on Komé et al. One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens
  9. Nutritional ketosis modulates the methylation of cancer-related genes in patients with obesity and in breast cancer cells
  10. Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial
  11. Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk
  12. Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study
  13. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study
  14. Real‐world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2S‐RWD)
  15. Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study
  16. Survey on Endocrinology and Nutrition undergraduate teaching in Spain-2021
  17. RECALSEEN 2021. Resources and quality in the Endocrinology and Nutrition units of the National Health System of Spain
  18. RECALSEEN 2021. La atención al paciente en las unidades de Endocrinología y Nutrición del Sistema Nacional de Salud
  19. Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
  20. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition
  21. Glycaemic and insulinaemic impact of a diabetes-specific oral nutritional supplement with Extra-Virgin Olive Oil in patients with type 2 diabetes mellitus at nutritional risk: a randomized, double-blind, crossover, multicentre clinical trial (DIACARE)
  22. Organoleptic evaluation of a diabetic-specific oral nutritional supplement with extra virgin olive oil in patients at nutritional risk and type 2 diabetes mellitus: Double-blind, randomized, crossover and multicenter clinical trial (DIACARE)
  23. Review of real-life teduglutide experience
  24. GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain
  25. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN)
  26. Demographic and clinical characteristics of a Spanish population of people living with type 1 diabetes who practice nonprofessional sports: The DIABESPORT survey
  27. Resumen ejecutivo del documento de consenso sobre: recomendaciones clínicas para la práctica del deporte en personas con diabetes mellitus (Guía RECORD). Actualización 2021. Área de Conocimiento de Diabetes Mellitus de la Sociedad Española de Endocrino...
  28. Epigenetic Effects of Healthy Foods and Lifestyle Habits from the Southern European Atlantic Diet Pattern: A Narrative Review
  29. Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
  30. Eye symptoms in acromegaly, beyond visual field alteration
  31. Síntomas oculares en la acromegalia, más allá de la alteración del campo visual
  32. Transcriptomic analysis of patients with clinical suspicion of maturity-onset diabetes of the young (MODY) with a negative genetic diagnosis
  33. Reducing Metabolic Syndrome through a Group Educational Intervention Program in Adults with Obesity: IGOBE Program
  34. Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study
  35. How the COVID-19 pandemic has affected the training of Endocrinology and Nutrition Residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition
  36. Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study
  37. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus
  38. Immunonutrition, evidence and experiences
  39. Effectiveness to promote weight loss maintenance and healthy lifestyle habits of a group educational intervention program in adults with obesity: IGOBE program
  40. DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain
  41. The NADYA-SENPE Home Enteral Nutrition Registry in Spain: years 2018 and 2019
  42. People living with type 1 diabetes point of view in COVID-19 times (COVIDT1 study): Disease impact, health system pitfalls and lessons for the future
  43. Risk Factors for Hypoglycemia in Inpatients with Total Parenteral Nutrition and Type 2 Diabetes: A Post HOC Analysis of the Insupar Study
  44. Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study
  45. Home and Ambulatory Artificial Nutrition (NADYA) Group Report. Home parenteral nutrition in Spain, 2018
  46. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain
  47. Tiroiditis subaguda por dasatinib
  48. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial
  49. Documento de abordaje integral de la diabetes tipo 2
  50. Nutrición parenteral domiciliaria en España 2017. Informe del Grupo de Nutrición Artificial Domiciliaria y Ambulatoria NADYA
  51. Effect of Telephone-Delivered Interventions on Glycemic Control in Type 2 Diabetes Treated with Glargine Insulin
  52. Registro del grupo nadya-senpe de nutrición enteral domiciliaria en españa; años 2016 y 2017
  53. Nutrición Parenteral Domiciliaria en España 2016; informe del Grupo de Nutrición Artificial Domiciliaria y Ambulatoria NADYA
  54. Acid–base safety during the course of a very low-calorie-ketogenic diet
  55. Utilidad en la clínica de la goma guar parcialmente hidrolizada: revisión de la evidencia y experiencia
  56. Twitter: ¿el nuevo PubMed?
  57. Registro del Grupo NADYA-SENPE de nutrición enteral domiciliaria en España, años 2014 y 2015
  58. Nutrición Parenteral Domiciliaria en España durante 2015; informe del Grupo de Nutrición Artificial Domiciliaria y Ambulatoria NADYA
  59. Fe de errores de «Recomendaciones clínicas para la práctica del deporte en pacientes con diabetes mellitus (Guía RECORD). Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición (SEEN)»
  60. Diaphoresis and palpitation like first syntoms a tumor
  61. Recomendaciones clínicas para la práctica del deporte en pacientes con diabetes mellitus (Guía RECORD). Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición (SEEN)
  62. Polydipsia and polyuria, differential diagnosis in pregnancy
  63. Clinical experience with lixisenatide in patients with obesity and type 2 diabetes
  64. Dementia solved with surgery: Report of a case
  65. Demencia curada con cirugía: a propósito de un caso
  66. Lesión hipotalámica evanescente por linfoma B difuso de células grandes
  67. Hypothalamic evanescent lesion by diffuse large B-cell lymphoma
  68. Why obesity is multifactorial? Mixture of genetic predisposition, endocrine dysfunction and environmental factors: a case report